Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study

BACKGROUND: Cerebral malaria (CM) is associated with high mortality and morbidity caused by a high rate of transient or persistent neurological sequelae. Studies on immunomodulatory and neuroprotective drugs as ancillary treatment in murine CM indicate promising potential. The current study was cond...

Descripción completa

Detalles Bibliográficos
Autores principales: Lackner, Peter, Part, Andrea, Burger, Christoph, Dietmann, Anelia, Broessner, Gregor, Helbok, Raimund, Reindl, Markus, Schmutzhard, Erich, Beer, Ronny
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651188/
https://www.ncbi.nlm.nih.gov/pubmed/19250545
http://dx.doi.org/10.1186/1475-2875-8-36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651188/
https://www.ncbi.nlm.nih.gov/pubmed/19250545
http://dx.doi.org/10.1186/1475-2875-8-36

Ejemplares similares